Patents by Inventor Siglinde Moll

Siglinde Moll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation containing an LTB4-antagonist, as well as processes for the preparation thereof and the use thereof
    Publication number: 20050129768
    Abstract: The invention relates to a new pharmaceutical formulation, containing an LTB4 antagonist of formula I wherein A, R1, R2, R3 and R4 are defined as in claim 1, the pharmacologically acceptable acid addition salt, glycoside, O-sulphate or glucuronide thereof as active substance as well as optionally at least one pharmacologically acceptable excipient and/or carrier, the active substance being present as a solid solution or solid dispersion in a polymer matrix. The invention also relates to the preparation thereof and their use as pharmaceutical compositions as well as the solid solutions and dispersions per se.
    Type: Application
    Filed: October 29, 2004
    Publication date: June 16, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Thomas Bock, Siglinde Moll, Karl Weber, Ulrich Brauns
  • Pharmaceutical formulation containing an LTB4 antagonist
    Publication number: 20030119901
    Abstract: The invention relates to a new pharmaceutical formulation containing an LTB4 antagonist of formula I 1
    Type: Application
    Filed: July 10, 2002
    Publication date: June 26, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Robert Becker, Thomas Bock, Siglinde Moll, Rene Roscher, Ulrich Roth, Achim Sauer, Karl Weber